Africa: TB Clinical Trials: An UnPrecedented €34 Million Price Tag in Drug Development

[MSF] Geneva -- At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that helped identify a shorter, all-oral treatment regimen for drug-resistant tuberculosis (DR-TB),* which totalled €34 million. This is the first time the detailed costs of an individual clinical trial will have ever been shared publicly, challenging the lack of transparency around drug development and the prevailing public